4//SEC Filing
Ence Chuck 4
Accession 0001213900-21-001416
CIK 0001553643other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:06 PM ET
Size
7.8 KB
Accession
0001213900-21-001416
Insider Transaction Report
Form 4
Ence Chuck
CAO and COO
Transactions
- Award
Options to purchase common stock
2021-01-07+112,500→ 112,500 totalExercise: $33.43From: 2022-01-07Exp: 2031-01-07→ Common Stock (112,500 underlying) - Award
Options to purchase common stock
2021-01-07+112,500→ 112,500 totalExercise: $33.43From: 2021-04-07Exp: 2031-01-07→ Common Stock (112,500 underlying)
Footnotes (2)
- [F1]The options vest from the date of grant in equal quarterly increments of 6.25% over a four-year period.
- [F2]The options vest 25% one year from the date of grant, and thereafter in equal quarterly increments of 6.25% over the following three years. The options are subject to forfeiture upon failure by the Issuer to reach certain corporate objectives in 2021.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001697779
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 4:06 PM ET
- Size
- 7.8 KB